Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: Results from the Canadian Early Arthritis Cohort

Rheumatology (United Kingdom)

Volumn 55, Issue 10, 2016, Pages 1751-1762

  Hitchon, Carol A ^a,i   Boire, Gilles ^b   Haraoui, Boulos ^c   Keystone, Ed ^d   Pope, Janet ^e   Jamal, Shahin ^f   Tin, Diane ^g   Thorne, Carter ^g   Bykerk, Vivian P ^d,h,i   Ahluwalia, Vandana ⁱ   Akhavan, Pooneh ⁱ   Arbillaga, Hector ⁱ   Baron, Murray ⁱ   Bell, Mary ⁱ   Bensen, Bill ⁱ   Bessette, Louis ⁱ   Cividino, Alf ⁱ   Colmegna, Ines ⁱ   Haraoui, Paul ⁱ   Kinkhoff, Alice ⁱ   Kraishi, Majed ⁱ   Larche, Maggie ⁱ   Lyddell, Chris ⁱ   Menard, Henri ⁱ   Mosher, Dianne ⁱ   Nair, Bindu ⁱ   Norris, Erin ⁱ   Penney, Chris ⁱ   Rubin, Laurence ⁱ   Shaw, Emily ⁱ   Sutton, Evelyn ⁱ   Villeneuve, Edith ⁱ   Zummer, Michel ⁱ   Bain, Lorna ⁱ   Buchignani, Maura ⁱ   Cheng, Cathy ⁱ   Cottrell, Jane ⁱ   Glenn, Nadine ⁱ   Guillet, Chantal ⁱ   Harris, Bob ⁱ   Harrison, Tanya ⁱ   Moyen, Melissa ⁱ   Kislinsky, Debbie ⁱ   L'Archevêque, Jolaine ⁱ   Larsen, Tiffany ⁱ   Legge, Gladys ⁱ   Luc, Lindsay ⁱ   Magnusson, Cheryl ⁱ   Maguire, Lyn ⁱ   Matthews, Julie ⁱ   McBain, Donna ⁱ   Ouellet, Michèle ⁱ   Papachristos, Angelo ⁱ   Poirier, Noemie ⁱ   Sniderman, Franci ⁱ   Strecko, Jayne ⁱ   Urroz, Lilian ⁱ   Vasconcelos, Sofia ⁱ   Wehlage, Annella ⁱ   White, Karen ⁱ   more..

^a UNIVERSITY OF MANITOBA   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c Institut de Rhumatologie de Montreal   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST JOSEPH S HEALTH CENTRE   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^h HOSPITAL FOR SPECIAL SURGERY   (United States)

ⁱ NONE

Author keywords

CATCH cohort; Comorbidity; DAS28; Early RA; Function; HAQ; Outcomes; Remission

Indexed keywords

LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; CANADA; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; AGE; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; COMPLICATION; LONGITUDINAL STUDY; MULTICENTER STUDY; PAIN; PATHOPHYSIOLOGY; SELF REPORT; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAIN; REMISSION INDUCTION; SELF REPORT; TREATMENT OUTCOME;

EID: 84991107996     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew061     Document Type: Article

References (47)

1. Ranganath VK, Maranian P, Elashoff DA et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology 2013;52:1809-17.
2. van den Hoek J, Roorda LD, Boshuizen HC et al. Longterm physical functioning and its association with somatic comorbidity and comorbid depression in patients with established rheumatoid arthritis: a longitudinal study. Arthritis Care Res 2013;65:1157-65.
3. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:885-906.
4. Ursum J, Korevaar JC, Twisk JW et al. Prevalence of chronic diseases at the onset of inflammatory arthritis: a population-based study. Family Pract 2013;30:615-20.
5. Ursum J, Nielen MM, Twisk JW et al. Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study. BMC Fam Pract 2013;14:199.
6. Gabriel SE, Crowson CS, O'Fallon WM. Comorbidity in arthritis. J Rheumatol 1999;26:2475-9.
7. Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 2015;144:365-73.
8. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
9. Innala L, Moller B, Ljung L et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Therapy 2011;13:R131.
10. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011;7:399-408.
11. Kerola AM, Kerola T, Kauppi MJ et al. Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Ann Rheum Dis 2013;72:1826-9.
12. Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology 2014;53:2143-54.
13. Arnold MB, Bykerk VP, Boire G et al. Are there differences between young-and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology 2014;53:1075-86.
14. Nakajima A, Inoue E, Shimizu Y et al. Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis. Clin Rheumatol 2015;34:441-9.
15. Mjaavatten MD, Radner H, Yoshida K et al. Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis. J Rheumatol 2014;41:2370-8.
16. Bykerk VP, Jamal S, Boire G et al. The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. J Rheumatol 2012;39:2071-80.
17. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Aletaha D, Neogi T, Silman AJ et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
19. Aletaha D, Ward MM, Machold KP et al. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005;52:2625-36.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
21. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003;49:156-63.
22. Dougados M, Soubrier M, Antunez A et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 2014;73:62-8.
23. Tiippana-Kinnunen T, Kautiainen H, Paimela L, Leirisalo-Repo M. Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol 2013;42:451-6.
24. Kroot EJ, van Gestel AM, Swinkels HL et al. Chronic comorbidity in patients with early rheumatoid arthritis: a descriptive study. J Rheumatol 2001;28:1511-7.
25. Kapetanovic MC, Lindqvist E, Simonsson M et al. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease. Scand J Rheumatol 2010;39:353-9.
26. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G. Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 2004;31:58-65.
27. Rupp I, Boshuizen HC, Roorda LD et al. Poor and good health outcomes in rheumatoid arthritis: the role of comorbidity. J Rheumatol 2006;33:1488-95.
28. Kapetanovic MC, Lindqvist E, Nilsson JA et al. Development of functional impairment and disability in rheumatoid arthritis patients followed for 20 years-relation to disease activity, joint damage and comorbidity. Arthritis Care Res 2015;67:340-8.
29. Ellerby N, Mattey DL, Packham J, Dawes P, Hider SL. Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis. Ann Rheum Dis 2014;73:e74.
30. Cabrera-Marroquin R, Contreras-Yanez I, Alcocer-Castillejos N, Pascual-Ramos V. Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes. Clin Exp Rheumatol 2014;32:904-13.
31. Visser K, van der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis 2009;68:1094-9.
32. Zwikker HE, van Dulmen S, den Broeder AA, van den Bemt BJ, van den Ende CH. Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Prefer Adherence 2014;8:1635-45.
33. van den Bemt BJ, van den Hoogen FH, Benraad B et al. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol 2009;36:2164-70.
34. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 2011;32:7-24.
35. Berk M, Williams LJ, Jacka FN et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200.
36. Rethorst CD, Bernstein I, Trivedi MH. Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES). J Clin Psychiatry 2014;75:e1428-32.
37. Chen CY, Tsai CY. From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis? Rheumatology 2014;53:205-12.
38. McLean MH, Dieguez D Jr, Miller LM, Young HA. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 2015;64:332-41.
39. Wong LE, Huang WT, Pope JE et al. Effect of age at menopause on disease presentation in early rheumatoid arthritis: Results from the Canadian Early Arthritis Cohort. Arthritis Care Res 2015;67:616-23.
40. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121 (10 Suppl 1): S9-14.
41. Radner H, Smolen JS, Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:536-41.
42. Kerola AM, Kauppi MJ, Nieminen TV et al. Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis. Scand J Rheumatol 2015;44:87-92.
43. Mussen L, Boyd T, Bykerk V et al. Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort. Rheumatol Int 2013;33:457-65.
44. Mackey RH, Kuller LH, Deane KD et al. Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the Women's Health Initiative. Arthritis Rheumatol 2015;67:2311-22.
45. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
46. Hudson M, Bernatsky S, Taillefer S et al. Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease. J Clin Epidemiol 2008;61:654-62.
47. Horton M, Rudick RA, Hara-Cleaver C, Marrie RA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 2010;35:83-90.